These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30397059)

  • 1. Pharmacodynamics of Minocycline against
    Tarazi Z; Sabet M; Dudley MN; Griffith DC
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30397059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Neutropenic Murine Pneumonia Model.
    Zhou J; Ledesma KR; Chang KT; Abodakpi H; Gao S; Tam VH
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of minocycline and polymyxin B combination against Acinetobacter baumannii.
    Bowers DR; Cao H; Zhou J; Ledesma KR; Sun D; Lomovskaya O; Tam VH
    Antimicrob Agents Chemother; 2015 May; 59(5):2720-5. PubMed ID: 25712362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of minocycline against Acinetobacter baumannii studied in a pharmacokinetic model of infection.
    Alfouzan WA; Noel AR; Bowker KE; Attwood MLG; Tomaselli SG; MacGowan AP
    Int J Antimicrob Agents; 2017 Dec; 50(6):715-717. PubMed ID: 28705678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model.
    Koomanachai P; Kim A; Nicolau DP
    J Antimicrob Chemother; 2009 May; 63(5):982-7. PubMed ID: 19279050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
    Housman ST; Hagihara M; Nicolau DP; Kuti JL
    J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of Meropenem against Acinetobacter baumannii in a Neutropenic Mouse Thigh Infection Model.
    Sabet M; Tarazi Z; Griffith DC
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988101
    [No Abstract]   [Full Text] [Related]  

  • 8. In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii.
    Yang YS; Lee Y; Tseng KC; Huang WC; Chuang MF; Kuo SC; Lauderdale TL; Chen TL
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4047-54. PubMed ID: 27114274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced anti-biofilm activity of the minocycline-and-gallium-nitrate using niosome wrapping against Acinetobacter baumannii in C57/BL6 mouse pneumonia model.
    Shamkani F; Barzi SM; Badmasti F; Chiani M; Mirabzadeh E; Zafari M; Shafiei M
    Int Immunopharmacol; 2023 Feb; 115():109551. PubMed ID: 36621329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
    Scheetz MH; Qi C; Warren JR; Postelnick MJ; Zembower T; Obias A; Noskin GA
    Antimicrob Agents Chemother; 2007 May; 51(5):1621-6. PubMed ID: 17307973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of TetB identifies minocycline-susceptible isolates of Acinetobacter baumannii.
    Lomovskaya O; Sun D; Rubio-Aparicio D; Nelson KJ; Thamlikitkul V; Dudley MN; Redell MA
    Int J Antimicrob Agents; 2018 Sep; 52(3):404-406. PubMed ID: 29665446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
    Morfin-Otero R; Dowzicky MJ
    Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy.
    Choi IS; Lee YJ; Wi YM; Kwan BS; Jung KH; Hong WP; Kim JM
    Int J Antimicrob Agents; 2016 Aug; 48(2):175-80. PubMed ID: 27423416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of minocycline alone or in combination in multidrug-resistant Acinetobacter baumannii isolates.
    Rodríguez CH; Nastro M; Vay C; Famiglietti A
    J Med Microbiol; 2015 Oct; 64(10):1196-1200. PubMed ID: 26238719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacodynamic simulation to evaluate tigecycline in treatment of nosocomial pneumonia caused by multidrug-resistant Acinetobacter baumannii.
    Ni WT; Liang BB; Cai Y; Liu YP; Bai N; Cui JC; Wang R
    Pak J Pharm Sci; 2014 May; 27(3):463-7. PubMed ID: 24811802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida albicans Airway Colonization Facilitates Subsequent Acinetobacter baumannii Pneumonia in a Rat Model.
    Tan X; Chen R; Zhu S; Wang H; Yan D; Zhang X; Farmakiotis D; Mylonakis E
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3348-54. PubMed ID: 27001817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii.
    Bishburg E; Bishburg K
    Int J Antimicrob Agents; 2009 Nov; 34(5):395-401. PubMed ID: 19665876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is minocycline a solution for multidrug-resistant Acinetobacter baumannii?
    Neonakis IK; Spandidos DA; Petinaki E
    Future Microbiol; 2014; 9(3):299-305. PubMed ID: 24762305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro tigecycline and carbapenem susceptibilities of clinical Acinetobacter baumannii isolates].
    Nayman Alpat S; Aybey AD; Akşit F; Ozgüneş I; Kiremitçi A; Usluer G
    Mikrobiyol Bul; 2010 Oct; 44(4):641-5. PubMed ID: 21063976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.